– Calando Pharmaceuticals Inc. Is a majority owned subsidiary of Arrowhead Research Corporation About Calando Pharmaceuticals Inc. : is a biopharmaceutical company developing proprietary technologies at Caltech, siRNA. Therapeutics, and small molecule create nanoparticle drug conjugates. Calando uses its innovative Cyclosert and RONDEL nanoparticle systems long-standing long-standing obstacle to effective delivery and targeting for oligonucleotide and small molecule therapeutics.

Factors that may could cause the actual results or developments to differ materially include, among others: the risk that CALAA-01 or IT – 101 appear promising in early research and clinical trials, but no safety and / or efficiency may in larger-scale or later stage clinical trials, the risk that regulatory approvals may not be obtained, the risks associated with dependence upon key personnel, the risks associated associated with reliance on collaborative partners and others for further clinical trials, development, manufacturing and commercialization of our product candidates; the costs, delays and uncertainties associated with our scientific research, product development, clinical trials and approval process associated our history of operating losses since our inception, competition, litigation, and risks associated with our ability to protect our intellectual property and raise the necessary financing to fund our activities and associated research.Capacity of short term memory affects the impact the grounds the bigger the capacitance, the better the effect Currently researchers carrying out on trials the development of effective ways of training short-term memory.